Linden LLC

Solara Acquires Huey’s Home Medical

November 30, 2018 | For Immediate Release

Chula Vista, CA (November 30, 2018) – Solara Medical Supplies (“Solara”), a leading direct-to-patient supplier of advanced diabetic devices, including continuous glucose monitors, insulin pumps and other supplies for the intensively managed diabetic, announced today the acquisition of Huey’s Home Medical, Inc. (“HHM”), an Illinois-based direct-to-patient provider of durable medical equipment and supplies.

“The addition of HHM in Illinois enhances Solara’s existing Midwest presence in Michigan and Ohio and demonstrates our ongoing commitment to improving our offering to patients, suppliers and payors” said Keith Crawford, CEO of Solara. HHM has been operating in Illinois since 2004 and has developed a track record of dedication to patient education and personal service.

Ron Labrum, Chairman of Solara and Operating Partner at Linden Capital Partners, added, “HHM adds a key geography for Solara and builds upon our strategy to enhance patient service, broaden our national reach and increase value for our manufacturer partners.”

HHM represents Solara’s second acquisition following its investment from Linden Capital Partners in May 2018.

Brown & Fortunato PC served as legal advisor to Solara.

About Solara Medical Supplies
Solara Medical Supplies, LLC is a leading direct-to-patient distributor of advanced diabetes therapy products including continuous glucose monitors, durable insulin pumps, and patch insulin pumps. Founded in 2002, Solara is headquartered in Chula Vista, California and operates additional offices in Michigan, Texas, Alabama, and Ohio. For more information, please visit

About Linden Capital Partners
Linden Capital Partners is a Chicago-based private equity firm focused exclusively on leveraged buyouts in the healthcare industry. Linden’s strategy is based upon three elements: i) healthcare specialization, ii) integrated private equity and operating expertise, and iii) strategic relationships with large corporations. Linden invests in middle market platforms in the medical products, specialty distribution, pharmaceutical, and services segments of healthcare. For more information, please visit